Biolife Solutions (BLFS) Gains from Investment Securities (2018 - 2023)

Biolife Solutions (BLFS) has 6 years of Gains from Investment Securities data on file, last reported at -$415000.0 in Q4 2023.

• On a quarterly basis, Gains from Investment Securities rose 70.48% year-over-year to -$415000.0 in Q4 2023; TTM through Sep 2024 was -$415000.0, a 86.97% increase from a year earlier, with the FY2023 full-year figure at -$2.2 million, up 53.87% from the prior year.
• Gains from Investment Securities for Q4 2023 stood at -$415000.0, up from -$1.6 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for BLFS reached as high as $19.7 million in Q1 2019 and fell as low as -$3.6 million in Q2 2019.
• Historically, Gains from Investment Securities has averaged $366250.0 across 5 years, with a median of -$453000.0 in 2021.
• Across the five-year window, Gains from Investment Securities slumped 6900.0% in 2021 and soared 1775.71% in 2022, its largest moves.
• Year by year, Gains from Investment Securities stood at $50000.0 in 2019, then slumped by 4246.0% to -$2.1 million in 2020, then jumped by 186.3% to $1.8 million in 2021, then plunged by 178.59% to -$1.4 million in 2022, then jumped by 70.48% to -$415000.0 in 2023.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were -$415000.0 in Q4 2023, -$1.6 million in Q3 2023, and -$918000.0 in Q2 2023.